What is NDC 14537-881?

14537-881 is the product NDC for Sodium Citrate 4% w/v Anticoagulant, Trisodium citrate dihydrate 4 g/100mL injection, solution, listed with the FDA by Terumo BCT, Ltd. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Sodium Citrate 4% w/v Anticoagulant (Trisodium citrate dihydrate).

Terumo BCT, Ltd, NDC labeler code 14537. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sodium Citrate 4% w/v Anticoagulant?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sodium Citrate 4% w/v Anticoagulant NDC 14537-881

NDC codes

FDA NDC Directory

Product NDC (as listed)14537-881Labeler and product segments. Claims need a package NDC.

Product NDC at billing width14537-0881Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
14537-881-25	14537088125	30 BAG in 1 CARTON (14537-881-25) / 250 mL in 1 BAGMarketed from Jun 26, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Citrate 4% w/v Anticoagulant
Generic name (nonproprietary): trisodium citrate dihydrate
Active ingredients: Trisodium citrate dihydrate — 4 g/100mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Terumo BCT, LtdNDC labeler code 14537
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application BA 125608
Marketing start: Jun 26, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)
Identifiers: Product ID 14537-881_dc65eed1-d14f-4b51-8a84-479852e44ddfSPL ID dc65eed1-d14f-4b51-8a84-479852e44ddfSPL set ID 0775912f-f14a-4967-ac00-c8c1b36040bfUNII B22547B95K
Pharmacologic class: Anti-coagulant; Calculi Dissolution Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N414537088125 followed by a unit qualifier and the quantity

Package 14537-0881-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 23, 2025.

Indications (excerpt from the label)

SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. [See Dosage and Administration (2) .] SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 14537-881

What is NDC 14537-881?: 14537-881 is the product NDC for Sodium Citrate 4% w/v Anticoagulant, Trisodium citrate dihydrate 4 g/100mL injection, solution, listed with the FDA by Terumo BCT, Ltd. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sodium Citrate 4% w/v Anticoagulant (Trisodium citrate dihydrate).
What is the active ingredient?: Trisodium citrate dihydrate.
Who is the labeler?: Terumo BCT, Ltd, NDC labeler code 14537. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sodium Citrate 4% w/v Anticoagulant?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under BA 125608

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BA 125608
Product	Strength	Form · route	Labeler	Product NDC
Sodium Citrate w/v Anticoagulanttrisodium citrate dihydrate	Trisodium citrate dihydrate 4 g/100mL	Injection, SolutionIntravenous	Terumo BCT, Ltd	14537-883

Sodium Citrate 4% w/v Anticoagulant (Trisodium citrate dihydrate) NDC 14537-881